On the interaction of an anticancer trisubstituted naphthalene diimide with G-quadruplexes of different topologies: a structural insight.
Journal
Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011
Informations de publication
Date de publication:
02 12 2020
02 12 2020
Historique:
accepted:
22
10
2020
revised:
29
09
2020
received:
06
07
2020
pubmed:
11
11
2020
medline:
30
12
2020
entrez:
10
11
2020
Statut:
ppublish
Résumé
Naphthalene diimides showed significant anticancer activity in animal models, with therapeutic potential related to their ability to strongly interact with G-quadruplexes. Recently, a trifunctionalized naphthalene diimide, named NDI-5, was identified as the best analogue of a mini-library of novel naphthalene diimides for its high G-quadruplex binding affinity along with marked, selective anticancer activity, emerging as promising candidate drug for in vivo studies. Here we used NMR, dynamic light scattering, circular dichroism and fluorescence analyses to investigate the interactions of NDI-5 with G-quadruplexes featuring either parallel or hybrid topology. Interplay of different binding modes of NDI-5 to G-quadruplexes was observed for both parallel and hybrid topologies, with end-stacking always operative as the predominant binding event. While NDI-5 primarily targets the 5'-end quartet of the hybrid G-quadruplex model (m-tel24), the binding to a parallel G-quadruplex model (M2) occurs seemingly simultaneously at the 5'- and 3'-end quartets. With parallel G-quadruplex M2, NDI-5 formed stable complexes with 1:3 DNA:ligand binding stoichiometry. Conversely, when interacting with hybrid G-quadruplex m-tel24, NDI-5 showed multiple binding poses on a single G-quadruplex unit and/or formed different complexes comprising two or more G-quadruplex units. NDI-5 produced stabilizing effects on both G-quadruplexes, forming complexes with dissociation constants in the nM range.
Identifiants
pubmed: 33170272
pii: 5973464
doi: 10.1093/nar/gkaa1001
pmc: PMC7708068
doi:
Substances chimiques
Antineoplastic Agents
0
DNA, Neoplasm
0
Imides
0
Ligands
0
Naphthalenes
0
Solutions
0
naphthalenediimide
22291-04-9
Guanine
5Z93L87A1R
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12380-12393Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Références
J Am Chem Soc. 2012 Feb 8;134(5):2723-31
pubmed: 22280460
Sci Rep. 2015 May 20;5:10479
pubmed: 25990684
Oncotarget. 2016 Aug 2;7(31):49649-49663
pubmed: 27351133
Int J Mol Sci. 2020 Mar 13;21(6):
pubmed: 32183038
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1303-1311
pubmed: 27902935
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1429-1447
pubmed: 27865995
J Mol Biol. 2008 Sep 19;381(5):1145-56
pubmed: 18619463
Sci Rep. 2015 Jun 16;5:11385
pubmed: 26077929
Chemistry. 2017 Apr 27;23(24):5814-5823
pubmed: 28276093
Nucleic Acids Res. 2002 Apr 15;30(8):1782-8
pubmed: 11937632
J Org Chem. 2013 Aug 16;78(16):8065-73
pubmed: 23869544
PLoS One. 2014 Jul 17;9(7):e102711
pubmed: 25033211
J Med Chem. 2018 Mar 22;61(6):2500-2517
pubmed: 29356532
Nat Rev Mol Cell Biol. 2017 May;18(5):279-284
pubmed: 28225080
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2843-2851
pubmed: 28780124
Top Curr Chem. 2013;330:211-42
pubmed: 22851158
Dalton Trans. 2016 May 28;45(20):8587-600
pubmed: 27126508
Nucleic Acids Res. 2017 Feb 28;45(4):1606-1618
pubmed: 27923993
Nat Rev Drug Discov. 2011 Apr;10(4):261-75
pubmed: 21455236
Molecules. 2020 Jan 21;25(3):
pubmed: 31972988
J Org Chem. 2016 Mar 4;81(5):1746-56
pubmed: 26866984
Methods. 2007 Dec;43(4):264-77
pubmed: 17967697
Sci Rep. 2013 Oct 21;3:3005
pubmed: 24141643
Molecules. 2019 Jan 24;24(3):
pubmed: 30682828
Methods. 2012 May;57(1):11-24
pubmed: 22633887
Cancer Chemother Pharmacol. 2015 Dec;76(6):1113-32
pubmed: 26391154
Anal Chem. 2014 May 6;86(9):4126-30
pubmed: 24725064
Chemistry. 2016 Feb 24;22(9):3170-81
pubmed: 26808655
Nucleic Acids Res. 2018 May 4;46(8):4301-4315
pubmed: 29648656
Cancer Treat Rev. 2013 Aug;39(5):444-56
pubmed: 22841437
Genes (Basel). 2016 May 26;7(6):
pubmed: 27240403
J Med Chem. 2013 Apr 11;56(7):2959-74
pubmed: 23514618
J Biomol NMR. 1997 Oct;10(3):255-62
pubmed: 9390403
J Phys Chem B. 2020 Apr 9;124(14):2778-2787
pubmed: 32182431
Org Biomol Chem. 2016 Jul 26;14(30):7238-49
pubmed: 27383473
J Am Chem Soc. 2006 Aug 2;128(30):9963-70
pubmed: 16866556
Nucleic Acids Res. 2004 Jan 13;32(1):e13
pubmed: 14722228
Nat Protoc. 2018 Mar;13(3):551-564
pubmed: 29470465
Eur J Med Chem. 2019 Feb 1;163:295-306
pubmed: 30529547
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1341-1352
pubmed: 28130159
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
Molecules. 2013 Oct 10;18(10):12500-37
pubmed: 24152672
Anal Chim Acta. 2018 Nov 7;1030:133-141
pubmed: 30032762
Bioorg Med Chem. 2011 Dec 1;19(23):7151-7
pubmed: 22041170
Int J Biol Macromol. 2020 May 15;151:1163-1172
pubmed: 31747572
Cancers (Basel). 2017 Dec 20;9(12):
pubmed: 29261171
Int J Mol Sci. 2018 Nov 21;19(11):
pubmed: 30469358
Chem Commun (Camb). 2016 Oct 25;52(87):12792-12805
pubmed: 27779264